Pregled bibliografske jedinice broj: 470493
Metabolic syndrome- the consequence of lifelong treatment of bipolar affective disorder
Metabolic syndrome- the consequence of lifelong treatment of bipolar affective disorder // Psychiatria Danubina, 22 (2010), 2; 381-384 (podatak o recenziji nije dostupan, prikaz, znanstveni)
CROSBI ID: 470493 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Metabolic syndrome- the consequence of lifelong treatment of bipolar affective disorder
Autori
Dadić-Hero, Elizabeta ; Ružić, Klementina ; Grahovac, Tanja ; Petranović, Duška ; Graovac, Mirjana ; Žarković Palijan, Tija
Izvornik
Psychiatria Danubina (0353-5053) 22
(2010), 2;
381-384
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, prikaz, znanstveni
Ključne riječi
bipolar affective disorder ; metabolic syndrome
Sažetak
Mood disturbances are characteristic and dominant feature of Mood disorders. Bipolar Affective Disorder (BAD) is a mood disorder which occurs equally in both sexes. BAD may occur in comorbidity with other mental diseases and disorders such as: Anorexia Nervosa, Bulimia Nervosa, Attention Deficit, Panic Disorder and Social Phobia. However, medical disorders (one or more) can also coexist with BAD. Metabolic syndrome is a combination of metabolic disorders that increase the risk of developing cardiovascular disease. A 61-year old female patient has been receiving continuous and systematic psychiatric treatment for Bipolar Affective Disorder for the last 39 years. The first episode was a depressive one and it occurred after a child delivery. Seventeen years ago the patient developed diabetes (diabetes type II), and twelve years ago arterial hypertension was diagnosed. High cholesterol and triglyceride levels as well as weight gain were objective findings. During the last nine years she has been treated for lower leg ulcer. Since metabolic syndrome includes abdominal obesity, hypertension, diabetes mellitus, increased cholesterol and serum triglyceride levels, the aforesaid patient can be diagnosed with Metabolic Syndrome. When treating Bipolar Affective Disorder, the antipsychotic drug choice should be careful and aware of its side-effects in order to avoid the development or aggravation of metabolic syndrome.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka
Profili:
Tija Žarković Palijan
(autor)
Mirjana Graovac
(autor)
Duška Petranović
(autor)
Elizabeta Dadić-Hero
(autor)
Tanja Grahovac Juretić
(autor)
Klementina Ružić
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- Social Science Citation Index (SSCI)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
Uključenost u ostale bibliografske baze podataka::
- EMBASE (Excerpta Medica)
- Psychological abstracts/Psyc INFO
- Chemical Abstracts (CA)
- Index Medicus/MEDLINE
- Cambridge Scientific Abstracts/Social Services Abstracts
- Science Citation Index Expanded (SCIE)
- Social Sciences Citation Index (SSCI)
- scopus.com
- BioMedWorld.com
- Social Srisearch
- Journal Citation Reports/Social Science Edition
- Journal Citation Reports/Science Edition